Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney ...

The results after switching from intravenous (IV) to subcutaneous (SC) treatment at Week 30 were comparable with that of maintaining CT-P13 SC up to Week 54 (up to Week 64 for safety profile)1 The ...

Your doctor may recommend this exam if you have blood in your urine or pain in your side or lower back. This test lets your doctor see the size and shape of your bladder, kidneys, and ureters, and how ...

AMSTERDAM--(BUSINESS WIRE)--New data presented at the Annual European Congress of Rheumatology (EULAR 2018) show that the subcutaneous (SC) formulation of CT-P13 is comparable in terms of efficacy and ...